Business Context and Reporting Period
This Form 8-K filing by Anthem, Inc. (now Elevance Health, Inc.) covers the period ending May 10, 2018, with the earliest event reported on May 8, 2018. The filing addresses corporate governance changes regarding the departure of a senior executive.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial statement data.
Material Changes
The primary material change reported is the resignation of Brian T. Griffin. He notified the Company on May 8, 2018, of his resignation as Executive Vice President of Anthem, Inc. and Chief Executive Officer of IngenioRx, a subsidiary of the Company. His resignation became effective on May 10, 2018.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the executive departure. The resignation was announced via a press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the effective date of Brian T. Griffin's resignation (May 10, 2018).
- Confirm the specific roles vacated: Executive Vice President of Anthem, Inc. and CEO of IngenioRx.
- Review the attached press release (Exhibit 99.1) for details on the reason for departure and any succession plans.
- Note that this filing contains no financial performance data for the period.